True prevalence of long-COVID in a nationwide, population cohort study

A study published in Nature recently (30/11/23) aimed to determine the true prevalence of long Covid symptoms in Scotland that are attributable to prior SARS-CoV-2 infection. It included almost 200,000 adults – half with confirmed symptomatic infections and half matched controls never infected.

 

At 6 months follow-up, 64.5% of previously infected people reported at least 1 ongoing symptom compared to 50.8% of those never infected. The crude prevalence of symptoms attributable to infection was 13.8%. After adjustment for confounders, the attributable prevalence was 6.6%.

 

Similar attributable prevalence estimates were obtained at 12 months (6.5%) and 18 months (10.4%), indicating symptoms may persist up to 18 months post-infection for around 1 in 10 people.

 

Prevalence was higher in women, those more vaccinated pre-infection, and people infected later in the pandemic. It was lower in those with more pre-existing conditions. Following severe infection, prevalence reached 79-84% depending on follow-up time.

 

Many common symptoms reported post-infection are non-specific. The findings suggest the likelihood of mistakenly attributing symptoms to long Covid when they may be unrelated. Careful diagnosis is warranted.

 

In conclusion, around 6-10% of infected people have ongoing symptoms for up to 18 months attributable to SARS-CoV-2 infection. This is lower than some previous estimates. Support for long Covid sufferers and more research on causes and treatments should be priorities.

 

You can read the full report here.

more insights